These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35931132)
21. Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. Cureton N; Korotkova I; Baker B; Greenwood S; Wareing M; Kotamraju VR; Teesalu T; Cellesi F; Tirelli N; Ruoslahti E; Aplin JD; Harris LK Theranostics; 2017; 7(15):3715-3731. PubMed ID: 29109771 [TBL] [Abstract][Full Text] [Related]
22. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial. Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556 [TBL] [Abstract][Full Text] [Related]
23. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Salafia CM; Minior VK; Pezzullo JC; Popek EJ; Rosenkrantz TS; Vintzileos AM Am J Obstet Gynecol; 1995 Oct; 173(4):1049-57. PubMed ID: 7485292 [TBL] [Abstract][Full Text] [Related]
24. Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe. Frusca T; Todros T; Lees C; Bilardo CM; Am J Obstet Gynecol; 2018 Feb; 218(2S):S783-S789. PubMed ID: 29422211 [TBL] [Abstract][Full Text] [Related]
25. Association between hypertensive disorders and fetal growth restriction in twin compared with singleton gestations. Proctor LK; Kfouri J; Hiersch L; Aviram A; Zaltz A; Kingdom J; Barrett J; Melamed N Am J Obstet Gynecol; 2019 Sep; 221(3):251.e1-251.e8. PubMed ID: 31029663 [TBL] [Abstract][Full Text] [Related]
26. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial. Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479 [TBL] [Abstract][Full Text] [Related]
27. A liquid chromatographic-mass spectrometric procedure for analysis of pentaerythrityl tetranitrate metabolites - Development, validation and application to ovine serum and human plasma samples. Städtler M; Wissenbach D; Wissenbach DK; Franke L; Pastuschek J; Schleussner E; Allison B; Peters FT; Groten T J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124028. PubMed ID: 38330519 [TBL] [Abstract][Full Text] [Related]
28. Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia. Man AWC; Chen M; Zhou Y; Wu Z; Reifenberg G; Daiber A; Münzel T; Xia N; Li H J Mol Med (Berl); 2020 Sep; 98(9):1287-1299. PubMed ID: 32748067 [TBL] [Abstract][Full Text] [Related]
29. T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies. Hansen DN; Sinding M; Petersen A; Christiansen OB; Uldbjerg N; Peters DA; Frøkjær JB; Sørensen A Am J Obstet Gynecol MFM; 2022 May; 4(3):100578. PubMed ID: 35114424 [TBL] [Abstract][Full Text] [Related]
30. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction. McLaughlin K; Hobson SR; Chandran AR; Agrawal S; Windrim RC; Parks WT; Bowman AW; Sovio U; Smith GC; Kingdom JC Am J Obstet Gynecol; 2022 Feb; 226(2S):S1145-S1156.e1. PubMed ID: 34461078 [TBL] [Abstract][Full Text] [Related]
31. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315 [TBL] [Abstract][Full Text] [Related]
32. Placental features of fetal vascular malperfusion and infant neurodevelopmental outcomes at 2 years of age in severe fetal growth restriction. Gardella B; Dominoni M; Caporali C; Cesari S; Fiandrino G; Longo S; De Vito GB; Naboni C; Tonduti D; Perotti G; Orcesi S; Spinillo A Am J Obstet Gynecol; 2021 Oct; 225(4):413.e1-413.e11. PubMed ID: 33812813 [TBL] [Abstract][Full Text] [Related]
33. Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial. Ling HZ; Guy GP; Bisquera A; Poon LC; Nicolaides KH; Kametas NA Ultrasound Obstet Gynecol; 2019 Jul; 54(1):51-57. PubMed ID: 30246326 [TBL] [Abstract][Full Text] [Related]
34. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188 [TBL] [Abstract][Full Text] [Related]